Skip to main content
. 2024 Dec 17;16(12):1607. doi: 10.3390/pharmaceutics16121607

Table 4.

ADMET profiling of the best 10 hits.

ADMET Parameters 1 2 3 4 5 6 7 8 9 10
Absorption
Water solubility (log mol/L) −1.88 −2.24 −3.1 −2.01 −4.12 −3.561 −2.929 −3.808 −4.441 −2.97
Caco2 permeability (log Papp in 10−6 cm/s) 0.14 −0.31 −0.17 −0.49 0.67 1.337 1.027 1.21 1.376 0.108
Intestinal absorption (human) (% Absorbed) 42.81 32.3 45 25.50 93.15 95.325 96.606 96.34 91.364 61.309
P-glycoprotein substrate (Yes/No) NO Yes Yes Yes Yes No No Yes No No
Distribution
BBB permeability (log BB) −0.71 −1.007 −1.38 −1.09 −0.04 −0.007 −0.313 0.142 0.098 −0.953
CNS permeability (log PS) −3.18 −4.15 −3.80 −3.92 −2.132 −2.176 −2.333 −2.135 −3.22 −3.414
Metabolism
CYP2D6 substrate (Yes/No) No No No No No No No Yes No No
CYP3A4 substrate (Yes/No) No No No No Yes Yes Yes Yes No No
CYP1A2 inhibitor (Yes/No) No No No No Yes No No No No No
CYP2C19 inhibitor (Yes/No) No No No No No No No No Yes No
CYP2C9 inhibitor (Yes/No) No No No No No No No No No No
CYP2D6 inhibitor (Yes/No) No No No No No No No No No No
CYP3A4 inhibitor (Yes/No) No No No No No No No No No No
Excretion
Total Clearance (log mL/min/kg) 0.93 1.04 0.225 0.524 0.196 1.101 0.506 0.762 −0.374 1.05
Renal OCT2 substrate (Yes/No) No No No No No Yes No Yes No No
Toxicity
AMES toxicity (Yes/No) No No No No No No No No No No
Max. tolerated dose (human) (log mg/kg/day) 0.89 1.50 0.847 −0.224 0.039 −0.465 0.2 −0.741 0.171 0.906
hERG I inhibitor (Yes/No) No No No No No No No No No No
Hepatotoxicity (Yes/No) Yes Yes Yes No Yes No No No No Yes